Oral contraceptive use and vitamin nutrition status of malnourished women-effects of continuous and intermittent vitamin supplements.
D001219:Aspartate Aminotransferases / Q000378:metabolism; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004912:Erythrocytes / Q000201:enzymology; D004997:Ethinyl Estradiol; D005260:Female; D005182:Flavin-Adenine Dinucleotide / Q000494:pharmacology; D005980:Glutathione Reductase / Q000097:blood; D006801:Humans; D009644:Norgestrel; D009748:Nutrition Disorders / Q000503:physiopathology*; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D012256:Riboflavin; D014815:Vitamins / Q000627:therapeutic use; D014977:Xanthurenates / Q000652:urine
D003276:Contraceptives, Oral; D014815:Vitamins; D014977:Xanthurenates; D005182:Flavin-Adenine Dinucleotide; D009644:Norgestrel; D004997:Ethinyl Estradiol; D011732:Pyridoxal Phosphate; D005980:Glutathione Reductase; D001219:Aspartate Aminotransferases; D012256:Riboflavin